These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 14743970)

  • 41. Polysaccharide matrices for microbially triggered drug delivery to the colon.
    Sinha VR; Kumria R
    Drug Dev Ind Pharm; 2004 Feb; 30(2):143-50. PubMed ID: 15089048
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of guar gum from different sources for the preparation of prolonged-release or colon-specific dosage forms.
    Acartürk F; Celkan A
    Pharm Dev Technol; 2009; 14(3):271-7. PubMed ID: 19519181
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development of pH- and enzyme-controlled, colon-targeted, pulsed delivery system of a poorly water-soluble drug: preparation and in vitro evaluation.
    Lai H; Lin K; Zhang W; Zhang Z; Jie L; Wu Y; He Q
    Drug Dev Ind Pharm; 2010 Jan; 36(1):81-92. PubMed ID: 19640246
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro and in vivo evaluation of guar gum matrix tablets for oral controlled release of water-soluble diltiazem hydrochloride.
    Al-Saidan SM; Krishnaiah YS; Patro SS; Satyanaryana V
    AAPS PharmSciTech; 2005 Jul; 6(1):E14-21. PubMed ID: 16353958
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Utilizing guar gum for development of "tabs in cap' system of losartan potassium for chronotherapeutics.
    Gangwar G; Kumar A; Pathak K
    Int J Biol Macromol; 2015 Jan; 72():812-8. PubMed ID: 25268456
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Guar gum as a microbially degradable component for an oral colon delivery system based on a combination strategy: formulation and in vitro evaluation.
    Moutaharrik S; Meroni G; Soggiu A; Foppoli A; Cerea M; Palugan L; Caloni F; Martino PA; Gazzaniga A; Maroni A
    Drug Deliv Transl Res; 2024 Mar; 14(3):826-838. PubMed ID: 37824039
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Metronidazole loaded pectin microspheres for colon targeting.
    Vaidya A; Jain A; Khare P; Agrawal RK; Jain SK
    J Pharm Sci; 2009 Nov; 98(11):4229-36. PubMed ID: 19492406
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Highly specific colon-targeted transformable capsules containing indomethacin immediate-release pellets for colon cancers therapy.
    Yang C; Zhang Y; Cai P; Yuan S; Ma Q; Song Y; Wei H; Wu Z; Wu Z; Qi X
    J Drug Target; 2020 Jan; 28(1):102-110. PubMed ID: 31100991
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Guar gum as potential film coating material for colon-specific delivery of fluorouracil.
    Ji CM; Xu HN; Wu W
    J Biomater Appl; 2009 Jan; 23(4):311-29. PubMed ID: 18667456
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Application of guar gum biopolymer in the prescription of tablets with sodium ibuprofen--quality tests and pharmaceutical availability in vitro.
    Berner-Strzelczyk A; Kołodziejska J; Zgoda MM
    Polim Med; 2006; 36(4):3-11. PubMed ID: 17402228
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Budesonide-loaded guar gum microspheres for colon delivery: preparation, characterization and in vitro/in vivo evaluation.
    Liu Y; Zhou H
    Int J Mol Sci; 2015 Jan; 16(2):2693-704. PubMed ID: 25629228
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Assessment of levetiracetam bioavailability from targeted sites in the human intestine using remotely activated capsules and gamma scintigraphy: Open-label, single-dose, randomized, four-way crossover study in healthy male volunteers.
    Stockis A; Sargentini-Maier ML; Otoul C; Connor A; Wilding I; Wray H
    Clin Ther; 2010 Sep; 32(10):1813-21. PubMed ID: 21194605
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Formulation development and in-vitro/in-vivo correlation for a novel Sterculia gum-based oral colon-targeted drug delivery system of azathioprine.
    Nath B; Nath LK
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1765-73. PubMed ID: 23110370
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy of guar gum-based ronidazole capsules as a treatment for Tritrichomonas foetus infection in cats.
    Grellet A; Makhlouf SE; Desquilbet L; Hovhannessian F; Boogaerts C; Dore V; Anthony M; Espana B; Prouillac C; Kirilov P; Polack B; Perrot S
    J Feline Med Surg; 2017 Feb; 19(2):177-184. PubMed ID: 26662037
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pulsatile systems for colon targeting of budesonide: in vitro and in vivo evaluation.
    Yehia SA; Elshafeey AH; Elsayed I
    Drug Deliv; 2011 Nov; 18(8):620-30. PubMed ID: 22111975
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development, evaluation and pharmacokinetics of time-dependent ketorolac tromethamine tablets.
    Vemula SK; Veerareddy PR
    Expert Opin Drug Deliv; 2013 Jan; 10(1):33-45. PubMed ID: 23199134
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hydration, erosion, and release behavior of guar-based hydrophilic matrix tablets containing total alkaloids of Sophora alopecuroides.
    Zhao W; Song L; Deng H; Yao H
    Drug Dev Ind Pharm; 2009 May; 35(5):594-602. PubMed ID: 19040179
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Formulation and pharmacokinetics of colon-specific double-compression coated mini-tablets: Chronopharmaceutical delivery of ketorolac tromethamine.
    Vemula SK
    Int J Pharm; 2015 Aug; 491(1-2):35-41. PubMed ID: 26056929
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prospective of guar gum and its derivatives as controlled drug delivery systems.
    Prabaharan M
    Int J Biol Macromol; 2011 Aug; 49(2):117-24. PubMed ID: 21596058
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In Vivo Evaluation of 5-ASA Colon-Specific Tablets Using Experimental-Induced Colitis Rat Animal Model.
    Sawarkar SP; Deshpande SG; Bajaj AN; Nikam VS
    AAPS PharmSciTech; 2015 Dec; 16(6):1445-54. PubMed ID: 26017284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.